|
Volumn 89, Issue 11, 2004, Pages
|
Evaluation of gemcitabine in relapsed or refractory multiple myeloma.
a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
ADULT;
AGED;
CLINICAL TRIAL;
FEMALE;
HUMAN;
LETTER;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
MULTIPLE MYELOMA;
PHASE 2 CLINICAL TRIAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIMETABOLITES, ANTINEOPLASTIC;
DEOXYCYTIDINE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
|
EID: 33646189942
PISSN: None
EISSN: 15928721
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (3)
|
References (0)
|